RTW Venture Fund Limited Appointment of Numis as Joint Broker (6369V)
06 April 2023 - 9:00PM
UK Regulatory
TIDMRTW
RNS Number : 6369V
RTW Venture Fund Limited
06 April 2023
LEI: 549300Q7EXQQH6KF7Z84
6 April 2023
RTW Venture Fund Limited
Appointment of Numis as Joint Broker
RTW Venture Fund Limited (the "Company"), a London Stock
Exchange-listed investment company focused on identifying
transformative assets with high growth potential across the life
sciences sector, is pleased to announce that it has appointed Numis
with immediate effect as Joint Corporate Broker alongside BofA
Securities, who remain Joint Corporate Broker.
For Further Information:
RTW Investments, LP +44 (0)20 7959 6361
Woody Stileman, Managing Director
Krisha McCune, Director, Client Service
Buchanan +44 (0)20 7466 5107
Charles Ryland
Henry Wilson
George Beale
Numis +44 (0)20 7260 1000
Freddie Barnfield
Nathan Brown
Euan Brown
BofA Securities +44 (0) 20 7628 1000
Edward Peel
Kieran Millar
Elysium Fund Management Limited +44 (0) 14 8181 0100
Joanna Duquemin Nicolle, Chief Executive Officer
Sadie Morrison, Managing Director
Morgan Stanley Fund Services USA LLC +1 (914) 225 8885
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment
fund focused on identifying transformative assets with high growth
potential across the biopharmaceutical and medical technology
sectors. Driven by a long-term approach to support innovative
businesses, RTW Venture Fund invests in companies developing
next-generation therapies and technologies that can significantly
improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a
leading healthcare-focused entrepreneurial investment firm with
deep scientific expertise and a strong track record of supporting
companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more
information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
APPGIGDSBDGDGXL
(END) Dow Jones Newswires
April 06, 2023 07:00 ET (11:00 GMT)
Rtw Biotech Opportunities (LSE:RTWG)
Historical Stock Chart
From Apr 2024 to May 2024
Rtw Biotech Opportunities (LSE:RTWG)
Historical Stock Chart
From May 2023 to May 2024